NEUROETHICS / PSYCHEDELICS I
Psychedelics
Treatment, insight, and illusion
A PATIENT’S REPORT
A loving cosmic plan.
Less fear of death.
A more enjoyable life.
on a comforting illusion?
Trevor asks: Would truth still matter if you were dying and afraid?
THE PHILOSOPHICAL PUZZLE
Insight and illusion
A new understanding
of oneself and reality.
A powerful certainty
that may be mistaken.
by worsening its understanding of reality?
Mackenzie asks: Does the value lie in revealing truth or changing how we see life?
THE INTERVENTION
Psychedelic therapy
Classic psychedelics: psilocybin, LSD, mescaline, DMT.
Characteristic effects depend importantly on 5-HT2A receptor activation.
Preparation
Screening, expectations,
and trust.
Session
Drug administration
and support.
Integration
Interpreting the experience
and returning to life.
The intervention includes a person, an experience, and a context.
William asks: Why do people respond to psychedelics differently?
THE CANCER-DISTRESS TRIAL
Symptoms after supported psilocybin sessions
51 analyzed participants with cancer-related distressHigh vs. very low dose; support in both conditions
High dose first
High dose
→Very low dose
Low dose first
Very low dose
→High dose
Each participant receives both conditions.
The first comparison occurs before the groups switch doses.
Sessions were 5 weeks apart.
have received the high dose.
William asks: How can a change in perspective persist after the drug wears off?
WHAT THE PATIENT REPORTS
Experience, interpretation, and belief
self and world dissolved.
larger consciousness.
the self is experienced.
independently of the body.
can change.
Noetic quality: the feeling of knowing or revelation.
Felt certainty leaves a question about justification.
Mackenzie asks: Can an experience give genuine knowledge if its apparent revelation is unproven?
THE DISPUTED CAUSAL INFERENCE
What explains the improvement?
Dose
Mystical-type
experience score
Symptom
improvement
The association alone does not establish that claim.
Mackenzie asks: Does an experience’s value lie in revealing truth or changing our outlook?
THE ARGUMENT
The comforting-delusion objection
- 1Naturalism is true.
- 2If naturalism is true, psychedelic therapy has a poor overall epistemic profile.
- 3A poor epistemic profile gives us reason to hesitate to recommend a therapy.
Trevor asks: Does truth still matter when someone is dying and afraid?
WAYS OF RESOLVING THE PUZZLE
Four responses
Metaphysical disclosure
Richards / HuxleyThe revelation is genuine.
Reject naturalism.
Benefit despite falsity
FlanaganRelief can outweigh epistemic costs.
Qualify the reason for caution.
Epistemic caution
LavazzaThe epistemic costs warrant hesitation.
Accept the objection.
Naturalistic epistemic benefit
LethebyBenefit need not depend on false metaphysics.
Challenge the poor-profile premise.
Trevor asks: Would you choose Nozick’s experience machine if you were dying and afraid?
LETHEBY’S ALTERNATIVE
A different understanding of oneself
Nothing
can change.
Could things
be different?
I can accept help.
My fear can change.
I can act differently.
can make new perspectives available.
Mackenzie asks: Does it matter whether a meaningful experience has a natural or supernatural source?
SYNAPTIC PLASTICITY
A brief event can leave a lasting change
READING THE EXPERIMENT
A brief train
of stimulation.
A stronger response
after it has ended.
Plasticity makes change possible.
It does not tell us which change is beneficial.
Hailey asks: How do negative experiences shape the reactions we later have?
GENUINE AND PLACEBO INSIGHTS
A helpful explanation can still be mistaken
“Boys should not cry” → an explanation of adult emotional habits.
What happened?
Is the childhood memory accurate?
What explains what?
Did it cause the adult difficulty?
Discovery puts an idea within reach. Justification requires evidence.
Hailey asks: Can reactions we call personality come from patterns learned without noticing?
COSTS, BENEFITS, AND AVAILABLE ALTERNATIVES
Epistemic innocence
Can an imperfect cognition still provide an epistemic benefit?
Epistemic benefit
The cognition improves understanding or makes inquiry possible.
No available alternative with fewer costs
At that time, an alternative route to the same epistemic benefit is unavailable.
Mackenzie asks: Can an experience give knowledge when its apparent revelation is uncertain?
PATIENT VALUES AND EPISTEMIC RISK
Who decides what matters?
Patient
Weighs relief, meaning, and truth in the context of their own life.
Clinician
Explains evidence and uncertainty; assesses reasonable treatment options.
Informed choice
The experience may feel certain. Its interpretation remains open to evaluation.
Consent leaves room to question what seemed revealed.
Trevor asks: Who weighs the risk of false belief, and what should patients be told?
RETURN TO THE PATIENT
The same relief, different explanations
Metaphysical reassurance
Consciousness survives
bodily death.
Revised self-understanding
My fear and my possibilities
look different.
Should we evaluate these changes differently?
What would distinguish their explanations?
Next: how changing the sense of self can change a life.
William asks: How does a new view of reality carry into sober life?
READING AND ATTRIBUTION
Assigned readings
Chris Letheby
Oxford University Press, 2021. Assigned: ch. 2, pp. 8–38; ch. 3, pp. 39–53; ch. 8, pp. 160–172 and 194–195. Optional bridge: ch. 6, pp. 110–123.
Dale Purves and colleagues
Sinauer / Oxford University Press, 2018. Chapter 8, pp. 176–188. Figure 8.7C, p. 177, after Malinow et al. (1989). Original panel reproduced from the assigned course excerpt.
Mackenzie asks: Can an experience give genuine knowledge if its apparent revelation is unproven?
STUDIES AND FIGURES
Empirical sources
Roland R. Griffiths and colleagues
Journal of Psychopharmacology 30 (2016), 1181–1197. DOI 10.1177/0269881116675513. Chart data: Table 4. Methods, limitations, and Figure 5 support the discussion of the study.
Stephen Ross and colleagues
Journal of Psychopharmacology 30 (2016), 1165–1180. DOI 10.1177/0269881116675512. A related trial of psilocybin for cancer-related anxiety and depression.
Calvin Ly and colleagues
Psychedelics Promote Structural and Functional Neural Plasticity
Cell Reports 23 (2018), 3170–3182. DOI 10.1016/j.celrep.2018.05.022. Supplemental empirical background, not an additional assigned reading.
William asks: How can a changed perspective last after someone is sober again?